Chloroquine is an anti-malarial and autoimmune disease drug, which has an antiviral activity. In vitro, the Chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV. Therefore, Chloroquine and Hydroxychloroquine are being studied for their potential treatment of coronavirus disease 2019. Those drugs are now recommended by the FDA, and multiple health organizations. This aims of this review is to explore the efficacy of the chloroquine and hydrochloroquine in the treatment of the novel COVID-19.
Bouhmou Ayoub*, Bzikha Reda, Bzikha Ilham and Bouchnafati Sanaa